Cargando…
Proteomic identification of cyclophilin A as a potential biomarker and therapeutic target in oral submucous fibrosis
Oral submucous fibrosis (OSF) is a pre-cancerous lesion, which is characterized by fibrosis of the oral submucosa. Despite large body of studies focusing on this disease, the molecular mechanisms underlying the progression of OSF remained unclear. In this study, 2-DE-based proteomic approaches were...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312388/ https://www.ncbi.nlm.nih.gov/pubmed/27533088 http://dx.doi.org/10.18632/oncotarget.11254 |
_version_ | 1782508198233636864 |
---|---|
author | Yuan, Yao Hou, Xiaohui Feng, Hui Liu, Rui Xu, Hao Gong, Wang Deng, Jing Sun, Chongkui Gao, Yijun Peng, Jieying Wu, Yingfang Li, Jiang Fang, Changyun Chen, Qianming |
author_facet | Yuan, Yao Hou, Xiaohui Feng, Hui Liu, Rui Xu, Hao Gong, Wang Deng, Jing Sun, Chongkui Gao, Yijun Peng, Jieying Wu, Yingfang Li, Jiang Fang, Changyun Chen, Qianming |
author_sort | Yuan, Yao |
collection | PubMed |
description | Oral submucous fibrosis (OSF) is a pre-cancerous lesion, which is characterized by fibrosis of the oral submucosa. Despite large body of studies focusing on this disease, the molecular mechanisms underlying the progression of OSF remained unclear. In this study, 2-DE-based proteomic approaches were employed to identify the differently expressed proteins between OSF and normal tissues. In total, 88 proteins were identified with altered expression levels, including CypA. Upregulation of CypA was further validated through immunohistochemistry staining combined with Q-PCR and western blot by using clinical samples. Statistical analyses reveal that CypA expression level is correlated to the progression of OSF. Finally, functional study reveals a pro-proliferative property of CypA in fibroblast cells by using multiple in vitro models. The present data suggest that CypA might be a potential biomarker and therapeutic target for OSF, and will lead to a better understanding of OSF pathogenesis. |
format | Online Article Text |
id | pubmed-5312388 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-53123882017-03-06 Proteomic identification of cyclophilin A as a potential biomarker and therapeutic target in oral submucous fibrosis Yuan, Yao Hou, Xiaohui Feng, Hui Liu, Rui Xu, Hao Gong, Wang Deng, Jing Sun, Chongkui Gao, Yijun Peng, Jieying Wu, Yingfang Li, Jiang Fang, Changyun Chen, Qianming Oncotarget Research Paper Oral submucous fibrosis (OSF) is a pre-cancerous lesion, which is characterized by fibrosis of the oral submucosa. Despite large body of studies focusing on this disease, the molecular mechanisms underlying the progression of OSF remained unclear. In this study, 2-DE-based proteomic approaches were employed to identify the differently expressed proteins between OSF and normal tissues. In total, 88 proteins were identified with altered expression levels, including CypA. Upregulation of CypA was further validated through immunohistochemistry staining combined with Q-PCR and western blot by using clinical samples. Statistical analyses reveal that CypA expression level is correlated to the progression of OSF. Finally, functional study reveals a pro-proliferative property of CypA in fibroblast cells by using multiple in vitro models. The present data suggest that CypA might be a potential biomarker and therapeutic target for OSF, and will lead to a better understanding of OSF pathogenesis. Impact Journals LLC 2016-08-12 /pmc/articles/PMC5312388/ /pubmed/27533088 http://dx.doi.org/10.18632/oncotarget.11254 Text en Copyright: © 2016 Yuan et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Yuan, Yao Hou, Xiaohui Feng, Hui Liu, Rui Xu, Hao Gong, Wang Deng, Jing Sun, Chongkui Gao, Yijun Peng, Jieying Wu, Yingfang Li, Jiang Fang, Changyun Chen, Qianming Proteomic identification of cyclophilin A as a potential biomarker and therapeutic target in oral submucous fibrosis |
title | Proteomic identification of cyclophilin A as a potential biomarker and therapeutic target in oral submucous fibrosis |
title_full | Proteomic identification of cyclophilin A as a potential biomarker and therapeutic target in oral submucous fibrosis |
title_fullStr | Proteomic identification of cyclophilin A as a potential biomarker and therapeutic target in oral submucous fibrosis |
title_full_unstemmed | Proteomic identification of cyclophilin A as a potential biomarker and therapeutic target in oral submucous fibrosis |
title_short | Proteomic identification of cyclophilin A as a potential biomarker and therapeutic target in oral submucous fibrosis |
title_sort | proteomic identification of cyclophilin a as a potential biomarker and therapeutic target in oral submucous fibrosis |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312388/ https://www.ncbi.nlm.nih.gov/pubmed/27533088 http://dx.doi.org/10.18632/oncotarget.11254 |
work_keys_str_mv | AT yuanyao proteomicidentificationofcyclophilinaasapotentialbiomarkerandtherapeutictargetinoralsubmucousfibrosis AT houxiaohui proteomicidentificationofcyclophilinaasapotentialbiomarkerandtherapeutictargetinoralsubmucousfibrosis AT fenghui proteomicidentificationofcyclophilinaasapotentialbiomarkerandtherapeutictargetinoralsubmucousfibrosis AT liurui proteomicidentificationofcyclophilinaasapotentialbiomarkerandtherapeutictargetinoralsubmucousfibrosis AT xuhao proteomicidentificationofcyclophilinaasapotentialbiomarkerandtherapeutictargetinoralsubmucousfibrosis AT gongwang proteomicidentificationofcyclophilinaasapotentialbiomarkerandtherapeutictargetinoralsubmucousfibrosis AT dengjing proteomicidentificationofcyclophilinaasapotentialbiomarkerandtherapeutictargetinoralsubmucousfibrosis AT sunchongkui proteomicidentificationofcyclophilinaasapotentialbiomarkerandtherapeutictargetinoralsubmucousfibrosis AT gaoyijun proteomicidentificationofcyclophilinaasapotentialbiomarkerandtherapeutictargetinoralsubmucousfibrosis AT pengjieying proteomicidentificationofcyclophilinaasapotentialbiomarkerandtherapeutictargetinoralsubmucousfibrosis AT wuyingfang proteomicidentificationofcyclophilinaasapotentialbiomarkerandtherapeutictargetinoralsubmucousfibrosis AT lijiang proteomicidentificationofcyclophilinaasapotentialbiomarkerandtherapeutictargetinoralsubmucousfibrosis AT fangchangyun proteomicidentificationofcyclophilinaasapotentialbiomarkerandtherapeutictargetinoralsubmucousfibrosis AT chenqianming proteomicidentificationofcyclophilinaasapotentialbiomarkerandtherapeutictargetinoralsubmucousfibrosis |